FDA Approves Xadago® (Safinamide) For Parkinson’s Disease

March 23, 2017 Scipreneur Private Limited 0

FDA Approves Xadago® (Safinamide) For Parkinson’s Disease By: Newron Pharmaceuticals News March 23, 2017  Newron Pharmaceuticals S.p.A. (“Newron”, SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, and its partners Zambon S.p.A. and US WorldMeds, [..]

FDA Approved Lexicon Pharma’s Xermelo® Against Carcinoid Syndrome Diarrhea

FDA Approved Lexicon Pharma’s Xermelo® Against Carcinoid Syndrome Diarrhea Source: FDA News and Lexpharma News March 9, 2017 The U.S. Food and Drug Administration today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled. Carcinoid [..]

GSK’s MUSCA Study Shows Nucala® Found Significantly Effective In Severe Asthma Patients

GSK’s MUSCA Study Shows Nucala® Found Significantly Effective In Severe Asthma Patients Issued From: London UK – LSE Announcement GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data demonstrating that severe asthma patients, whose disease is driven by eosinophilic inflammation, treated with first-in-class biologic Nucala® (mepolizumab) added-on to standard of care, achieved clinically and [..]

Roche’s Perjeta® Regimen For Breast Cancer Found to Greatly Extend Patients’ Lives: Phase III APHINITY study

Roche’s Perjeta® Regimen For Breast Cancer Found to Greatly Extend Patients’ Lives: Phase III APHINITY study By: Basel Roche News Perjeta plus Herceptin and chemotherapy showed a statistically significant improvement in invasive disease-free survival (iDFS) for people with HER2-positive early breast cancer (eBC) compared to Herceptin and chemotherapy alone Data will be discussed with [..]

Drug Treatment Could Combat Hearing Loss

Drug Treatment Could Combat Hearing Loss By: Anne Trafton | MIT News Office March 05, 2017 Within the inner ear, thousands of hair cells detect sound waves and translate them into nerve signals that allow us to hear speech, music, and other everyday sounds. Damage to these cells is one [..]

Startup Events In USA : March 2017

Startup Events In USA : March 2017 By: Vijay Soni, PhD | Founder & C.E.O. Scipreneur Whether you are starting a business just now, or you are already running a company, or you are just curious about what might be the business, entrepreneurship, technology, or digital marketing trends of tomorrow, [..]

FDA Approved Marketing of for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit

FDA Approved Marketing of for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit Source: Accelerate Diagnostic, Inc. March 1, 2017 Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for [..]

GOOD VENOM

February 23, 2017 Scipreneur Private Limited 0

GOOD VENOM February 23, 2017 By: University of Buffalo The problems began sometime before JB turned 2. He was, by appearance, a healthy boy. He had a brilliant smile, striking blonde hair and eyes the color of the sea. He was fast becoming enamored with the stuff of boyhood: cars, [..]

Mount Sinai Scientists Develops A New Reference Database (RepurposeDB) of Drug Repositioning and Decodes Molecular Code of Therapeutic Reuse

February 21, 2017 Scipreneur Private Limited 0

Mount Sinai Scientists Develops A New Reference Database (RepurposeDB) of Drug Repositioning and Decodes Molecular Code of Therapeutic Reuse By: Vijay Soni, Ph.D. | Founder & C.E.O Scipreneur February 21, 2017 A drug discovery project takes 8-12 years and costs 8-15 billion dollars. It relies on various avenues of pre-clinical development, [..]

Turning Food Poisoning Microbe Into Powerful Cancer Fighter

February 18, 2017 Scipreneur Private Limited 0

Turning Food Poisoning Microbe Into Powerful Cancer Fighter February 18, 2017 Source: Science Translational Medicine Cancer tends to stick around because it’s practically invisible to the body’s own defenses: The immune system doesn’t recognize the rogue cells because they aren’t foreign invaders. To activate the immune system to attack cancer, scientists [..]

Phase II study supports potential for Roche’s TECENTRIQ (atezolizumab) plus Avastin (bevacizumab) for local, advanced or metastatic renal cell carcinoma

February 18, 2017 Scipreneur Private Limited 0

Phase II study supports potential for Roche’s TECENTRIQ (atezolizumab) plus Avastin (bevacizumab) for local, advanced or metastatic renal cell carcinoma Study results also showed encouraging efficacy compared to sunitinib in those people whose disease expressed the PD-L1 (programmed death-ligand 1) protein Roche is evaluating TECENTRIQ plus Avastin in a Phase [..]

Novel Direction Towards Diabetes Cure

February 15, 2017 Scipreneur Private Limited 0

Novel Direction Towards Diabetes Cure By: Vijay Soni, Ph.D. | Founder and C.E.O. of Scipreneur A team of researchers at Weill Cornell Medical College (WCMC), New York have identified a novel trafficking pathway for a G-protein-coupled receptor (GPCR, the largest family of signaling receptors). The group has studied the trafficking [..]

10 Must Watch TED Talks for Every Entrepreneur

February 12, 2017 Scipreneur Private Limited 0

10 Must Watch TED Talks for Every Entrepreneur By: Vijay Soni, Ph.D. | Founder & C.E.O Scipreneur TED Talks are my favorite as they are full of vision on everything; from everyday science to advance level of scientific developments and from basic human nature to intricacies of life. They are real life experiences; [..]

FDA Approves Drug to Treat Duchenne Muscular Dystrophy

February 12, 2017 Scipreneur Private Limited 0

FDA Approves Drug to Treat Duchenne Muscular Dystrophy By: Marathon Pharma News February 9, 2017 Marathon Pharmaceuticals, LLC (Marathon), a U.S. research-based biopharmaceutical company focused solely on the development of new treatments for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of EMFLAZA™ (deflazacort) [..]

Startup Events In USA : February 2017

February 4, 2017 Scipreneur Private Limited 0

Startup Events In USA : February 2017 By: Vijay Soni, PhD, Founder & C.E.O. Scipreneur Whether you are starting a business just now, or you are already running a company, or you are just curious about what might be the business, entrepreneurship, technology, or digital marketing trends of tomorrow, this [..]

Microbial manufacturing

February 4, 2017 Scipreneur Private Limited 0

Microbial manufacturing By: Rob Matheson | MIT News Office February 4, 2017 Using advanced fermentation technology, industrial biotech startup Manus Bio hopes to make manufacturing flavors, fragrances, and other products greener and more cost-effective — and maybe create new products in the process. The MIT spinout has created a low-cost [..]

Novartis drug Votubia® receives EU approval to treat refractory partial-onset seizures in patients with TSC

January 31, 2017 Scipreneur Private Limited 0

Novartis drug Votubia® receives EU approval to treat refractory partial-onset seizures in patients with TSC Approval addresses unmet need as up to 60% of patients with TSC suffering from seizures become unresponsive to available anti-epileptic therapies[1]   Decision marks the third TSC-related indication for Votubia in the EU, where it [..]

Kripa Varanasi: Innovating at Interfaces

January 24, 2017 Scipreneur Private Limited 0

Kripa Varanasi: Innovating at Interfaces David L. Chandler | MIT News Office January 24, 2017 Ketchup’s sluggish pace as it oozes out of its bottle is a longstanding nuisance — but one that is about to be upended by a new product coming to market. The brainchild of MIT mechanical [..]